Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
NeueHealth | NEUE | Nov 25, 2024 | 4.86 | -2.80 |
Neumora Therapeutics | NMRA | Nov 25, 2024 | 9.67 | -0.72 |
Neuraxis | NRXS | Nov 25, 2024 | 3.03 | -0.66 |
Neurobo Pharmaceuticals | NRBO | Nov 25, 2024 | 2.42 | +2.11 |
Neurocrine Biosciences | NBIX | Nov 25, 2024 | 127.11 | +1.16 |
Neurogene | NGNE | Nov 25, 2024 | 22.32 | +9.93 |
NeuroMetrix | NURO | Nov 25, 2024 | 4.22 | -0.71 |
Neuronetics | STIM | Nov 25, 2024 | 0.97 | +9.62 |
NeuroOne | NMTC | Nov 25, 2024 | 0.61 | -10.01 |
Neuropace | NPCE | Nov 25, 2024 | 10.66 | +9.90 |
NeuroSense Therapeutics | NRSN | Nov 25, 2024 | 0.88 | -2.51 |
Nevro | NVRO | Nov 25, 2024 | 4.55 | +0.66 |
New America High Income Fund | HYB | Nov 25, 2024 | 8.22 | -0.60 |
New Concept Energy | GBR | Nov 25, 2024 | 1.18 | -3.28 |
New England Realty Associates LP Unit A | NEN | Nov 25, 2024 | 82.49 | 0.00 |
New Fortress Energy A | NFE | Nov 25, 2024 | 9.71 | -0.41 |
New Found Gold | NFGC | Nov 25, 2024 | 1.65 | +0.61 |
New Germany Fund | GF | Nov 25, 2024 | 8.02 | +0.63 |
New Gold | NGD | Nov 25, 2024 | 2.66 | -6.01 |
New Horizon Aircraft | HOVR | Nov 25, 2024 | 0.51 | +7.28 |
New Mountain Finance Corp | NMFC | Nov 25, 2024 | 11.80 | +0.34 |
New Oriental Education & Technology Group ADR | EDU | Nov 25, 2024 | 58.79 | +2.49 |
New Pacific Metals | NEWP | Nov 25, 2024 | 1.57 | -1.26 |
New Providence Acquisition II A | NPAB | Nov 25, 2024 | 11.30 | 0.00 |
New Providence Acquisition II Unit | NPABU | Nov 25, 2024 | 12.20 | 0.00 |
New Residential Investment A Pref | RITM-A | Nov 25, 2024 | 25.47 | +0.16 |
New Residential Investment B Pref | RITM-B | Nov 25, 2024 | 25.31 | +0.05 |
New Residential Investment C Pref | RITM-C | Nov 25, 2024 | 24.64 | +0.37 |
New Residential Investment D Pref | RITM-D | Nov 25, 2024 | 24.20 | -0.29 |
New York City REIT | NYC | Nov 25, 2024 | 8.60 | -1.15 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.